Getting a Vaccine to Market: The Timeline, the Process, and What to Expect with Dr. Beatrice Setnik of Altasciences

Globally, the Coalition for Epidemic Preparedness Innovations (CEPI) has invested more than $23 million US towards the development of a vaccine for COVID-19 and, as of now, it is expected that around 20 companies have potential medicines in various stages of development, with at least four existing medicines now in late phase clinical trials. Meanwhile there are around fifty projects exploring a variety of vaccine technologies, many of them industry/academia collaborations, and the most advanced entering early phase clinical trials... But what does this all mean? And when can we expect to see a vaccine? We chat with Dr. Beatrice Setnik of Altasciences to uncover the timeline and process in getting a vaccine to market. To learn more about Altasciences, please visit www.altasciences.com.